STTK: shattucklabs.com Kompaniya qiymatining sof foydaga nisbati
GADLEN platformasining bispesifik dori vositalarini yaratishdagi samaradorligi Shattuck Labs, Inc. (STTK) kompaniyasining muvaffaqiyatini belgilaydi, bu esa GURU.Markets dagi bozor tendentsiyasi bilan tasdiqlanadi, u yerda ko'rsatkich -7.70 darajasida turibdi. Ishlab chiqish jarayoni AQSh da olib borilmoqda, bu esa operatsion barqarorlikni va tashqi siyosiy mojarolardan himoyalanishni ta'minlaydi. Yuqori R&D xarajatlari va patent himoyasi yangi ishtirokchilar uchun kirishning sezilarli to'sig'ini yaratadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_STTK_-_Shattuck-Labs-Inc._-_PE-Multiple "STTK: Shattuck Therapeutics Biznesning o‘zini qoplash muddati 04.07.2022 - 12.11.2026 | 👁️GURU.Markets👁️")
Shattuck Labs Inc (STTK) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Shattuck Labs, Inc.|STTK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Shattuck Therapeutics|STTK - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Shattuck Labs, Inc.|STTK - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Shattuck Labs|Oraliq qoplama koeffitsiyenti shattucklabs.com
- foyda va bozor multiplikatorlari tafsilotlari:
STTK - Sof foyda|Kutilayotgan sof daromad Shattuck Labs, Inc.|STTK - P/E multiplikatori|Forvard P/E multiplikatori Shattuck Therapeutics|STTK - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Shattuck Labs, Inc.|STTK - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Shattuck Labs|STTK - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi shattucklabs.com|STTK - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Shattuck Labs, Inc.
Kompaniyaning har tomonlama tahlili:shattucklabs.com STTK
Bifunksional saraton terapiyalarini ishlab chiqish uchun ARC platformasini joriy etish ulkan investitsiyalarni talab qiladi, bu esa Shattuck Labs, Inc. (STTK) kompaniyasining biznes qiymatini baholashda narx-foyda koeffitsiyenti (P/E) tahlilini juda muhim qiladi. Ushbu koeffitsiyent bozorning kelajakdagi o'sish uchun qo'shimcha to'lov qilishga tayyorligini o'lchaydi; shuning uchun, hisobotdagi P/E koeffitsiyentining pasayishi yoki kirish nuqtasi, yoki bozor skeptitsizmining belgisi bo'lishi mumkin bo'lgan chegirmadan dalolat beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Tourmaline TRML|PGEN: P/E multiplikatori|pharming.com - Kompaniya qiymatining sof foydaga nisbati|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|P/E multiplikatori Upstream Bio, Inc.|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|Bozor narxining sof foydaga nisbati IMNM|Gossamer Bio, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KALV (kalvista.com)|SEPN: Narx-foyda koeffitsiyenti|PVLA - P/E multiplikatori|SVRA: P/E multiplikatori|Narx-foyda koeffitsiyenti Rigel Corp|Narxning foydaga nisbati AnaptysBio, Inc.|P/E multiplikatori astriatx.com|Narx-foyda koeffitsiyenti ENGN (enGene)|RAPT (RAPT Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Aerovate Therapeutics JBIO|Aclaris Therapeutics, Inc - Narxning foydaga nisbati|Kyverna Therapeutics - P/E multiplikatori|TLSA - P/E multiplikatori|CABA: P/E multiplikatori|VTYX (Ventyx Biosciences Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati Theratechnologies Inc|Avalo Therapeutics Inc (AVTX) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ELDN (Eledon Pharmaceuticals)|AGEN (agenusbio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori CLYM (Climb Bio)|Biznesning o‘zini qoplash muddati Zura Bio Ltd (ZURA)|ATYR - Narxning foydaga nisbati|ADAG (Adagene) - Narx-foyda multiplikatori|IMA: P/E multiplikatori|Narx-foyda koeffitsiyenti Equillium|Narx-foyda koeffitsiyenti CNTB|Immunic Inc (IMUX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|Biznesning o‘zini qoplash muddati inflarx.de|X4 Pharmaceuticals - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACET (Adicet Bio Inc.)|CELU: Narx-foyda koeffitsiyenti|INmune Bio Inc - Bozor narxining sof foydaga nisbati|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narxning foydaga nisbati SAB Biotherapeutics|akaritx.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ENLV|QTTB (q32bio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|Narx-foyda koeffitsiyenti AIM (AIM ImmunoTech Inc.)|ADTX (aditxt.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GRI (GRI Bio)|Biznesning o‘zini qoplash muddati XORTX Therapeutics Inc (XRTX)|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narx-foyda koeffitsiyenti CALI|P/E multiplikatori Affimed Therapeutics|Narxning foydaga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Narx-foyda multiplikatori|P/E multiplikatori IGMS (IGM Biosciences)|iteostherapeutics.com (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati TC BioPharm (Holdings) Plc TCBP|THRD: P/E multiplikatori
